SCHEMBL12433820

SCHEMBL12433820

CCCCCc1ccc(CCc2ccc(-c3ccc(CCCCc4c(C)cc(OCCCC)c(F)c4F)cc3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 10/20 0.42
RARA P10276 2/20 0.42
RARG P13631 1/20 0.42
MAPT P10636 5/20 0.40
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
MAPK1 P28482 3/20 0.40
HTT P42858 3/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
RAD52 P43351 2/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ALDH1A1 P00352 3/20 0.39
MTOR P42345 1/20 0.39
APAF1 O14727 2/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12433704 0.92 RARB (0.42) RARBRARARARGMAPTMEN1
SCHEMBL12433590 0.88 ESR1 (0.38) RARBRARARARGMAPTMEN1
SCHEMBL12433563 0.83 GABRA1 (0.36) MAPTMEN1KMT2AMAPK1HTT
SCHEMBL13980227 0.80 ENPP3 (0.36) MAPTMEN1KMT2AMAPK1HTT
SCHEMBL9399352 0.78 RARB (0.55) RARBRARARARGMAPTMEN1
SCHEMBL12433601 0.78 LMNA (0.36) MAPTMEN1KMT2AMAPK1HTT
SCHEMBL9497004 0.77 RARB (0.45) RARBRARARARGMAPTMEN1
SCHEMBL9563823 0.77 RARB (0.45) RARBRARARARGMAPTMEN1
SCHEMBL9399749 0.77 RARB (0.57) RARBRARARARGMAPTMEN1
SCHEMBL9398849 0.77 RARB (0.57) RARBRARARARGMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7981486-B2 Compound having alkyl on benzene ring, liquid crystal composition having the compound, and liquid crystal display device having the liquid crystal composition JNC CORPORATION (JP) 2011-07-19 US disclosed
US-7846513-B2 Compound having alkyl on benzene ring, liquid crystal composition having the compound, and liquid crystal display device having the liquid crystal composition CHISSO CORPORATION (JP) 2010-12-07 US disclosed
US-20090230356-A1 COMPOUND HAVING ALKYL ON BENZENE RING, LIQUID CRYSTAL COMPOSITION HAVING THE COMPOUND, AND LIQUID CRYSTAL DISPLAY DEVICE HAVING THE LIQUID CRYSTAL COMPOSITION CHISSO CORPORATION (JP) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090230356-A1 COMPOUND HAVING ALKYL ON BENZENE RING, LIQUID CRYSTAL COMPOSITION HAVING THE COMPOUND, AND LIQUID CRYSTAL DISPLAY DEVICE HAVING THE LIQUID CRYSTAL COMPOSITION BRD1, CNOT1, CXCR1 RARB 1782/4885RARA 1946/4885RARG 2840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.